PubMed

Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET.

Yoshida Y, Kurokawa T, Tsujikawa T, Okazawa H, Kotsuji F.

J Ovarian Res. 2009 Jun 16;2(1):7.PMID: 19527525 [PubMed - in process]Free PMC ArticleFree textRelated citations

Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.

Mortimer JE, Dehdashti F, Siegel BA, Katzenellenbogen JA, Fracasso P, Welch MJ.

Clin Cancer Res. 1996 Jun;2(6):933-9.PMID: 9816253 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.

Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D.

J Nucl Med. 2009 May;50 Suppl 1:64S-73S. Epub 2009 Apr 20. Review.PMID: 19380409 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.

Nasu K, Abe W, Takai N, Tomonari K, Narahara H.

Arch Gynecol Obstet. 2010 Jun 24. [Epub ahead of print]PMID: 20574659 [PubMed - as supplied by publisher]Related citations

Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.

Tsujikawa T, Yoshida Y, Mori T, Kurokawa T, Fujibayashi Y, Kotsuji F, Okazawa H.

Radiology. 2008 Aug;248(2):599-605. Epub 2008 Jun 6.PMID: 18539894 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature.

Gadducci A, Cosio S, Zola P, Landoni F, Maggino T, Sartori E.

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):21-31. Review.PMID: 17291227 [PubMed - indexed for MEDLINE]Related citations

Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.

Tsujikawa T, Yoshida Y, Kudo T, Kiyono Y, Kurokawa T, Kobayashi M, Tsuchida T, Fujibayashi Y, Kotsuji F, Okazawa H.

J Nucl Med. 2009 Oct;50(10):1598-604. Epub 2009 Sep 16.PMID: 19759112 [PubMed - indexed for MEDLINE]Related citations

Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients.

Kumar P, Mercer J, Doerkson C, Tonkin K, McEwan AJ.

J Pharm Pharm Sci. 2007;10(2):256s-265s.PMID: 17718929 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Combined approach of perioperative 18F-FDG PET/CT imaging and intraoperative 18F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer.

Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW Jr.

World J Surg Oncol. 2007 Dec 21;5:143.PMID: 18154677 [PubMed - in process]Free PMC ArticleFree textRelated citations

[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.

Been LB, Hoekstra HJ, Suurmeijer AJ, Jager PL, van der Laan BF, Elsinga PH.

Oral Oncol. 2009 Dec;45(12):e211-5. Epub 2009 Aug 18.PMID: 19692292 [PubMed - in process]Related citations

FDG-PET and CT in Evaluation of Chemotherapy in Advanced Head and Neck Cancer.

Dalsaso TA, Lowe VJ, Dunphy FR, Martin DS, Boyd JH, Stack BC.

Clin Positron Imaging. 2000 Jan;3(1):1-5.PMID: 10742676 [PubMed - as supplied by publisher]Related citations

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Al-Ibraheem A, Buck A, Krause BJ, Scheidhauer K, Schwaiger M.

J Oncol. 2009;2009:208725. Epub 2009 Aug 20.PMID: 19707528 [PubMed - in process]Free PMC ArticleFree textRelated citations

Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer.

Izuishi K, Yamamoto Y, Sano T, Takebayashi R, Masaki T, Suzuki Y.

J Gastrointest Surg. 2010 Jul;14(7):1151-8. Epub 2010 May 5.PMID: 20443074 [PubMed - in process]Related citations

Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels.

Jiménez-Bonilla J, Maldonado A, Morales S, Salud A, Zomeño M, Román J, Belon J, Moya F.

Clin Positron Imaging. 2000 Nov;3(6):231-236.PMID: 11378435 [PubMed - as supplied by publisher]Related citations

Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.

Signorelli M, Guerra L, Buda A, Picchio M, Mangili G, Dell'Anna T, Sironi S, Messa C.

Gynecol Oncol. 2009 Nov;115(2):231-5. Epub 2009 Aug 19.PMID: 19695685 [PubMed - indexed for MEDLINE]Related citations

The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG PET) in diagnosis of ovarian cancer.

Schröder W, Zimny M, Rudlowski C, Büll U, Rath W.

Int J Gynecol Cancer. 1999 Mar;9(2):117-122.PMID: 11240752 [PubMed - as supplied by publisher]Related citations

[Imaging of cancer activity and range of tumor involvement--applying to breast cancer]

Shibata K, Uno K, Wu J, Ko W.

Rinsho Byori. 2007 Jul;55(7):648-55. Review. Japanese. PMID: 17718061 [PubMed - indexed for MEDLINE]Related citations

Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery.

Risum S, Høgdall C, Markova E, Berthelsen AK, Loft A, Jensen F, Høgdall E, Roed H, Engelholm SA.

Int J Gynecol Cancer. 2009 May;19(4):600-4.PMID: 19509556 [PubMed - indexed for MEDLINE]Related citations

PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer.

Dehdashti F, Mortimer JE, Trinkaus K, Naughton MJ, Ellis M, Katzenellenbogen JA, Welch MJ, Siegel BA.

Breast Cancer Res Treat. 2009 Feb;113(3):509-17. Epub 2008 Mar 9.PMID: 18327670 [PubMed - indexed for MEDLINE]Related citations

Positron emission tomography application for gynecologic tumors.

Nakamoto Y, Saga T, Fujii S.

Int J Gynecol Cancer. 2005 Sep-Oct;15(5):701-9. Review.PMID: 16174216 [PubMed - indexed for MEDLINE]Related citations